Serum Neurofilament Light Chain as a Predictive Biomarker for Ischemic Stroke Outcome: A Systematic Review and Meta-analysis

Despite advances in early diagnosis and aggressive management of vascular risk factors, stroke remains the leading cause of death and long-term disability worldwide, and that ischemic stroke accounts for about 85% of all cerebrovascular diseases.1 Only a third of patients who survive an ischemic stroke recovers with minimal or no deficit, whereas the majority remains moderately or severely disabled lifetime.2 With the increasing of life expectancy and aging of the population, care for poststroke patients has become an important social and economic burden.
Source: Journal of Stroke and Cerebrovascular Diseases - Category: Neurology Authors: Source Type: research